Apogee Therapeutics, Inc. – NASDAQ:APGE
Apogee Therapeutics stock price today
$36.89
-8.92
-19.47%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 20 minutes
Apogee Therapeutics stock price monthly change
-4.60%
month
Apogee Therapeutics stock price quarterly change
-4.60%
quarter
Apogee Therapeutics stock price yearly change
+54.24%
year
Apogee Therapeutics key metrics
Market Cap | 2.74B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -2.08 |
Revenue | N/A |
EBITDA | -115.03M |
Income | -103.55M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeApogee Therapeutics stock price history
Apogee Therapeutics stock forecast
Apogee Therapeutics financial statements
| Jun 2023 | 0 | -18.88M | |
|---|---|---|---|
| Sep 2023 | 0 | -20.84M | |
| Dec 2023 | 0 | -31.73M | |
| Mar 2024 | 0 | -32.09M |
| Sep 2025 | 0 | -35.94M | |
|---|---|---|---|
| Dec 2025 | 0 | -46.04M | |
| Mar 2026 | 0 | -34.18M | |
| Jun 2026 | 0 | -34.87M |
Analysts Price target
Financials & Ratios estimates
| 2023-11-13 | -0.38 | -0.51 |
|---|---|---|
| 2024-03-05 | -0.45 | -0.32 |
| 2024-05-13 | -0.6 | -0.64 |
| Jun 2023 | 130667000 | 195.08M | 149.3% |
|---|---|---|---|
| Sep 2023 | 426421000 | 17.17M | 4.03% |
| Dec 2023 | 401404000 | 21.49M | 5.35% |
| Mar 2024 | 823659000 | 22.18M | 2.69% |
| Jun 2023 | -14.57M | 0 | -1.69M |
|---|---|---|---|
| Sep 2023 | -19.88M | -234.21M | 317.29M |
| Dec 2023 | -29.75M | -273.91M | -213K |
| Mar 2024 | -31.63M | -51.74M | 450.52M |
Apogee Therapeutics alternative data
| Sep 2023 | 25 |
|---|---|
| Oct 2023 | 25 |
| Nov 2023 | 25 |
| Dec 2023 | 25 |
| Jan 2024 | 25 |
| Feb 2024 | 25 |
| Mar 2024 | 91 |
| Apr 2024 | 91 |
| May 2024 | 91 |
| Jun 2024 | 91 |
| Jul 2024 | 91 |
Apogee Therapeutics other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2024 | 0 | 53335 |
| Sep 2024 | 0 | 46665 |
| Oct 2024 | 0 | 46665 |
| Nov 2024 | 0 | 21665 |
| Dec 2024 | 20000 | 26205 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | MCKENNA MARK C. director | Common Stock | 12,500 | $49.85 | $623,125 | ||
Purchase | MCKENNA MARK C. director | Common Stock | 12,500 | $49.85 | $623,125 | ||
Purchase | MCKENNA MARK C. director | Common Stock | 7,500 | $49.02 | $367,650 | ||
Purchase | MCKENNA MARK C. director | Common Stock | 7,500 | $49.02 | $367,650 | ||
Option | DAMBKOWSKI CARL officer: Chief Medical Officer | Common Stock | 1,815 | $22.86 | $41,491 | ||
Sale | DAMBKOWSKI CARL officer: Chief Medical Officer | Common Stock | 4,085 | $48.62 | $198,613 | ||
Sale | DAMBKOWSKI CARL officer: Chief Medical Officer | Common Stock | 455 | $50 | $22,750 | ||
Option | DAMBKOWSKI CARL officer: Chief Medical Officer | Stock Option (Right to Buy) | 1,815 | $22.86 | $41,491 | ||
Sale | DAMBKOWSKI CARL officer: Chief Medical Officer | Common Stock | 6,665 | $46.07 | $307,057 | ||
Sale | HENDERSON MICHAEL THOMAS director, officer.. | Common Stock | 13,328 | $46.5 | $619,752 |
-
What's the price of Apogee Therapeutics stock today?
One share of Apogee Therapeutics stock can currently be purchased for approximately $36.89.
-
When is Apogee Therapeutics's next earnings date?
Unfortunately, Apogee Therapeutics's (APGE) next earnings date is currently unknown.
-
Does Apogee Therapeutics pay dividends?
No, Apogee Therapeutics does not pay dividends.
-
How much money does Apogee Therapeutics make?
Apogee Therapeutics has a market capitalization of 2.74B. Apogee Therapeutics made a loss 83.99M US dollars in net income (profit) last year or -$0.64 on an earnings per share basis.
-
What is Apogee Therapeutics's stock symbol?
Apogee Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "APGE".
-
What is Apogee Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Apogee Therapeutics?
Shares of Apogee Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Apogee Therapeutics have?
As Jul 2024, Apogee Therapeutics employs 91 workers.
-
When Apogee Therapeutics went public?
Apogee Therapeutics, Inc. is publicly traded company for more then 2 years since IPO on 14 Jul 2023.
-
What is Apogee Therapeutics's official website?
The official website for Apogee Therapeutics is apogeetherapeutics.com.
-
Where are Apogee Therapeutics's headquarters?
Apogee Therapeutics is headquartered at 221 Crescent Street, Waltham, MA.
-
How can i contact Apogee Therapeutics?
Apogee Therapeutics's mailing address is 221 Crescent Street, Waltham, MA and company can be reached via phone at +65 03945230.
Apogee Therapeutics company profile:
Apogee Therapeutics, Inc.
apogeetherapeutics.comExchange:
NASDAQ
Full time employees:
91
Industry:
Biotechnology
Sector:
Healthcare
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
221 Crescent Street
Waltham, MA 02453
Waltham, MA 02453
CIK: 0001974640
ISIN: US03770N1019
CUSIP: 03770N101
